mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.02 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.02 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |